To validate this hypothesis, we further examined the signature score of Macro-SPP1 in BRCA, ccRCC, and OV, and found consistent results suggesting that Macro-SPP1 was significantly enriched in boundary regions in the above cancer types (Supplementary Fig. 5m). The gene discussed is SPP1; the disease is nonpapillary renal cell carcinoma.